Solid Biosciences

Solid Biosciences

Advance the development of its novel gene therapy platform.

Launch date
Employees
Market cap
CAD406m
Enterprise valuation
CAD181m (Public information from Sep 2024)
Boston Massachusetts (HQ)
Authorizing premium user...